Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation

  title={Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation},
  author={Amy Wang},
  journal={Pharmacy Practice},
  pages={65 - 71}
  • Amy Wang
  • Published 2012
  • Medicine
  • Pharmacy Practice
UNLABELLED Atrial fibrillation is a common cardiac arrhythmia, and has been a significant financial burden. [...] Key MethodRESULTS One study on dofetilide and 5 studies on ibutilide were identified. No studies were found on amiodarone. Patients with atrial fibrillation who received dofetilide and magnesium had higher rates of successful cardioversion as compared to those who only received dofetilide. Conversion rates were similar between the 2 treatment groups for patients with atrial flutter. As for ibutilide…Expand
Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department
The effectiveness and safety of ibutilide in this community ED setting were consistent with clinical trial results despite less stringent patient selection criteria. Expand
Improving an Outpatient Pathway for the Emergency Management of Atrial Fibrillation and Flutter.
This treatment pathway for the emergency department (ED) management of atrial fibrillation and flutter and will provide a model for ED leaders and key stakeholders creating a multidisciplinary comprehensive emergency care pathway for their own medical centers. Expand


Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
The administration of high doses of magnesium probably makes ib utilide a much safer agent, and magnesium increased the conversion efficacy of ibutilide. Expand
Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.
Intravenous amiodarone, at the doses used in this study, produces a modest but not significant benefit in converting acute atrial fibrillation to sinus rhythm. Expand
Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation
Intravenous ibutilide given in repeated doses is effective in rapidly terminating atrial fibrillation and flutter and under monitored conditions is an alternative to current cardioversion options. Expand
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.
  • J. Kalus, A. P. Spencer, +5 authors C. White
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2003
The efficacy of ibutilide was enhanced by concomitant administration with intravenous magnesium, and the conversion rate of atrial fibrillation or flutter with ibutilides was enhancedBy magnesium administration and the rate of administration was reduced in patients who received magnesium. Expand
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
Avoidance of polypharmacy with other potassium antagonists and unmonitored drug formulation changes are important in the management of all patients taking class III agents, but they are particularly crucial in women with additional risk factors for torsades de pointes. Expand
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
  • C. Coleman, N. Sood, D. Chawla, Ripple Talati, A. Ghatak, J. Kluger
  • Medicine
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2009
Conurrent use of intravenous magnesium is associated with an enhanced ability of dofetilide to successfully convert AF or AFL. Expand
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure. Expand
Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation.
Amiodarone is not superior to the other antiarrhythmic drugs conventionally used for the pharmacological cardioversion of recent-onset atrial fibrillation but is relatively safe in patients with structural heart disease and in those with depressed left ventricle function. Expand
Ibutilide: A New Class III Antiarrhythmic Agent
Ibutilide fumarate is a new antiarrhythmic agent recently approved for the conversion of atrial flutter and atrial fibrillation to normal sinus rhythm and was more effective in converting AFl and AF than sotalol and more effective than procainamide in randomized comparative trials. Expand
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
Dofetilide, a new class III antiarrhythmic agent, is moderately effective in cardioverting AF or AFl to SR and significantly effective in maintaining SR for 1 year. Expand